[Pharmacometry and biostatistics applicable to Pharmacology].
作者信息
Velasco Martin D A
出版信息
An R Acad Nac Med (Madr). 1974;91(2):219-69.
PMID:4601149
Abstract
摘要
相似文献
1
[Pharmacometry and biostatistics applicable to Pharmacology].[适用于药理学的药物计量学与生物统计学]
An R Acad Nac Med (Madr). 1974;91(2):219-69.
2
[Evaluation of the pharmacodynamic action of drugs widely used in medical practice].
Klin Med (Mosk). 1978 Jul;56(7):130-7.
3
Bioavailability studies and the clinical pharmacologist: correlation of drug distribution with clinical effects.生物利用度研究与临床药理学家：药物分布与临床效应的相关性
Int J Clin Pharmacol Biopharm. 1975 Jun;11(4):349-54.
4
The significance of properly designed pre-clinical studies in the clinical evaluation of new drugs.设计合理的临床前研究在新药临床评价中的意义。
Int Z Klin Pharmakol Ther Toxikol. 1970 Dec;4(1):6-20.
5
Clinical biostatistics. II. Statistics versus science in design of experiments.临床生物统计学。II. 实验设计中的统计学与科学
Clin Pharmacol Ther. 1970 Mar-Apr;11(2):282-92.
6
[Experience with phase I of clinical pharmacology in the registration of drugs].[药物注册中临床药理学I期的经验]
Arzneimittelforschung. 1973 Nov;23(11):Suppl:1677-8.
7
Statistics for clinical trials in asthma [proceedings].哮喘临床试验统计学[会议论文集]
Br J Dis Chest. 1977 Oct;71(4):227-8.
8
[Principles of clinical pharmacology].[临床药理学原理]
Ter Arkh. 1974;46(9):7-12.
9
The use of balanced incomplete block designs in comparative bioavailability trails.平衡不完全区组设计在比较生物利用度试验中的应用。
Biometrics. 1974 Jun;30(2):319-27.
10
Commentary. Reflections in a crystal ball.评论。对未来的展望。
Clin Pharmacol Ther. 1975 Jul;18(1):1-8. doi: 10.1002/cpt19751811.
Zotero 插件